Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion
Direct Source Verification:
This story is aggregated from Reuters (reuters.com). Full reporting rights and copyright belong to the primary publisher.
Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion reuters.com
Original Source
https://www.reuters.com/legal/litigation/merck-licenses-scibrunch-cancer-drug-deal-worth-up-213-billion-2026-09-28/
